Ursprung des Netzwerks ersten Grades von Diane R. Guinta
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 36 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Diane R. Guinta
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| VIVUS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Founder | |
| CERUS CORPORATION | Medical Specialties | Director/Board Member Chairman | |
| XOMA CORPORATION | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Aerogen, Inc.
 Aerogen, Inc. Medical SpecialtiesHealth Technology Aerogen, Inc. develops and manufactures aerosol products for treatment of respiratory disorders in the critical care setting. Its products include Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-C controller, and USB controller. The company is headquartered in Deerfield, IL. | Medical Specialties | Director/Board Member Chief Executive Officer General Counsel | |
| CORCEPT THERAPEUTICS INCORPORATED | Pharmaceuticals: Major | General Counsel Director/Board Member | |
Reliant Pharmaceuticals LLC
 Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Chief Executive Officer President Director of Finance/CFO General Counsel Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
SRI International
 SRI International Miscellaneous Commercial ServicesCommercial Services SRI International provides contract research and development services. It is an independent, nonprofit research institute conducting client-sponsored research and development for government agencies, commercial businesses, foundations, and other organizations. The company was founded in 1946 and is headquartered in Menlo Park, CA. | Miscellaneous Commercial Services | Human Resources Officer | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Graduate Degree Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Graduate Degree | |
EOS Biotechnology, Inc.
 EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Syracuse University | College/University | Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| San Jose State University | College/University | Undergraduate Degree Masters Business Admin | |
| University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
| University of California, Davis | College/University | Graduate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
| University of California, Santa Barbara | College/University | Undergraduate Degree Doctorate Degree | |
| University of Delaware | College/University | Undergraduate Degree | |
| University of Illinois | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal | |
Ilypsa, Inc.
 Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| PDL BIOPHARMA, INC. | Biotechnology | Corporate Officer/Principal | |
| CORIUM INTERNATIONAL INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Pearl Therapeutics, Inc.
 Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pearl Therapeutics, Inc. develops therapies for the treatment of chronic respiratory diseases. It offers respiratory product development, high quality therapies for COPD, Asthma and treatment and prevention of chronic respiratory diseases and asthma. The company was founded in 2006 by Sarvajna Dwivedi and is headquartered in Redwood City, CA. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
| RELYPSA INC | Pharmaceuticals: Major | Founder Founder | |
| The University of Alabama at Birmingham | College/University | Doctorate Degree | |
| Aquila Consulting Group Ltd. | Corporate Officer/Principal | ||
| PROTAGONIST THERAPEUTICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer President President General Counsel Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| UCSF School of Medicine | College/University | Doctorate Degree | |
Orbus Therapeutics, Inc.
 Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Chairman Founder | |
| FORTE BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Comera Life Sciences, Inc.
 Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million. | Pharmaceuticals: Major | Director/Board Member | |
| COMERA LIFE SCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 48 |
| Vereinigtes Königreich | 2 |
| Kanada | 2 |
| Irland | 2 |
Sektoral
| Health Technology | 34 |
| Consumer Services | 15 |
| Commercial Services | 3 |
Operativ
| Director/Board Member | 140 |
| Corporate Officer/Principal | 76 |
| Independent Dir/Board Member | 45 |
| Undergraduate Degree | 39 |
| Chairman | 33 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Ernest Mario | 44 |
| Howard Rosen | 26 |
| Phyllis Gardner | 19 |
| Bruce Cozadd | 19 |
| Martin S. Gerstel | 17 |
| Matthew Fust | 16 |
| James W. Young | 15 |
| Barbara Finck | 15 |
| Michael Miller | 14 |
| Jeff Hargroves | 14 |
| Peter Staple | 13 |
| Jane E. Shaw | 12 |
| Nandan Oza | 11 |
| Daniel Swisher | 10 |
| Detlef F. Albrecht | 10 |
- Börse
- Insiders
- Diane R. Guinta
- Unternehmensverbindungen
